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This analysis examined the association
of non-Hodgkin lymphoma (NHL) with pre-
diagnostic carotenoid levels, a marker for
a diet rich in fruits and vegetables. We
conducted a nested case-control study
within the Multiethnic Cohort with
271 NHL cases and 538 controls matched
on sex, ethnicity, location (Hawaii or Los
Angeles), birth year, date and time of
blood draw, and hours fasting before
blood draw. Serum carotenoid levels were
obtained by high-pressure liquid chroma-
tography with photodiode array detec-
tion. Conditional logistic regression
was used to calculate odds ratios (ORs)
according to tertiles of serum carote-
noids and trend tests using continuous
variables. Higher total serum carotenoids
(ORT3 vs T1  0.66 [0.46-0.96]; Ptrend  .02),
lycopene (OR  0.54 [0.38-0.78];
Ptrend  .003), and -cryptoxanthin
(OR  0.53 [0.36-0.78]; Ptrend  .003) were
associated with a lower risk of NHL. For
retinol (OR  0.90 [0.61-1.33]; Ptrend  .04),
a statistically significant inverse linear
trend was detected. Risk estimates re-
mained unchanged with adjustment for
NHL risk factors and were similar in anal-
yses stratified by sex and ethnicity; heter-
ogeneity with NHL subtype was detected
only for -carotene. Other carotenoids,
including -carotene, -carotene, lutein,
-cryptoxanthin, and zeaxanthin, showed
no association with risk. These data pro-
vide support for a protective role of
carotenoid-rich fruits and vegetables in
the etiology of NHL. (Blood. 2012;119(24):
5817-5823)
Introduction
Non-Hodgkin lymphoma (NHL) is the fifth most common cancer
in the United States,1 consisting of a heterogeneous group of
neoplasms that arise from the malignant transformation of B, T, and
natural killer cells of the immune system.2,3 Immune dysfunction is
thought to be the underlying basis of lymphoma development, but
well-characterized immunosuppressive states (HIV infection and
organ transplants) only partially explain the rising NHL risk over
the past decades.4 Based on the hypothesis that lymphoid tissues
are vulnerable to nutrient imbalances affecting metabolic pathways
and functions necessary to maintain immune functions,5,6 the
association between dietary factors and the risk of NHL has been
examined.7,8 Reports from retrospective case-control studies9-18
and prospective cohorts19-21 have found inverse associations be-
tween fruit intake, vegetable intake, or both and NHL, although
null findings also have been reported.22-26
Dietary carotenoids are a class of fat-soluble isoprenoid com-
pounds obtained primarily through the consumption of yellow-
orange fruits and vegetables, green leafy vegetables, and tomatoes;
they can function as antioxidants and some function as vitamin A
precursors.27 In a Western diet, carrots are the major source of
carotenes, spinach and other green leafy vegetables of lutein and
zeaxanthin, tomatoes of lycopene, and citrus of cryptoxanthins.27,28
Carotenoids reduce the production of reactive oxygen species
(ROS) in cell membranes and therefore may limit DNA damage
and the potential for the malignant transformation of immune cells
through the inhibition of radical species.29-31 Serum levels of
carotenoids are considered valid biologic markers for fruit and
vegetable intake, and, to date, they have not been investigated in
relation to NHL risk.27 For the present nested case-control study,
we examined whether prediagnostic serum levels of total and
specific carotenoids were associated with incident diagnoses of
NHL among individuals participating in the biospecimen subcohort
of the Multiethnic Cohort (MEC) Study.
Methods
Study design and population
The MEC is a longitudinal study designed to investigate the associations of
dietary, life style, and genetic factors with the incidence of cancer and was
previously described in detail.32 In brief, the cohort was established from
1993 to 1996 by mailing a self-administered, 26-page questionnaire to men
and women ages 45 to 75 years residing in Hawaii and California. To obtain
a multiethnic sample of blacks, Japanese Americans, Latinos, Native
Hawaiians, and whites, the primary sampling frame included drivers’
license records in both states, supplemented with voter registration lists in
Hawaii and Medicare files in California. More than 215 000 men and
women voluntarily completed the baseline questionnaire, indicating their
consent to participate in the study. The questionnaire included queries on
demographic characteristics, anthropometric measures, medical history,
family history of cancer, smoking history, reproductive and menstrual
history for women, cancer screening, occupational history, and physical
activity, as well as a food frequency questionnaire (FFQ).33
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The prospective MEC biospecimen subcohort was established from
2001 to 2006 by asking the  136 000 surviving and geographically
accessible cohort members to provide specimens of blood and urine.34
Blood samples were drawn and processed within 4 hours of collection by
centrifugation. Then, the components were aliquoted by automation into
0.5-mL cryotubes and stored in the vapor phase of liquid nitrogen
(186°C). For  95% of the participants contributing to the biorepository,
fasting blood samples ( 8 hours) were obtained. In total, 67 594 cohort
members (49.7% of eligible) contributed to the biorepository from which
the cases and controls were selected for the present study. comparing
individuals who provided specimens with those who did not, no substantial
difference by several demographic characteristics and cancer risk factors,
including family history of cancer, body mass index (BMI), fat and
vegetable intake, and physical activity, was detected; this suggests that the
biospecimen repository participants are broadly representative of all cohort
members. The study protocol was approved by the Institutional Review
Boards of the University of Hawaii and the University of Southern
California.
Case ascertainment and control selection
Cases for this analysis were participants from the 5 main ethnic groups,
black, white, Japanese American, Native Hawaiian, and Latino, who
contributed a prediagnostic fasting blood sample to the MEC biorepository
and received a diagnosis of NHL before February 28, 2010. Regular
linkages of the cohort to the Surveillance, Epidemiology, and End Results
cancer registries for Hawaii and California were conducted to identify
incident NHL cases diagnosed over the follow-up period. In an investiga-
tion within the entire cohort, the average out-migration rate for members
was only 3.7% after 7 years and 7.6% after 15 years of follow-up, with
California as the primary destination for Hawaii participants. Therefore,
case ascertainment is thought to be close to complete. Diagnoses of NHL
were classified according to the International Classification of Diseases for
Oncology, Third Edition and aggregated into common NHL subtypes in
accordance with the proposed hierarchical classification of lymphoid
neoplasms for epidemiologic research.3
Two controls per case were randomly selected from the eligible pool of
participants who were alive and free of a diagnosis of NHL at the age of the
case’s diagnosis and who matched the case on year of birth ( 1 year),
location (Hawaii or California), ethnicity, date of blood draw ( 1 year),
time of blood draw ( 2 hours), and hours fasting before blood draw
( 6, 6 to 8, 8 to 10, 10). In total, 275 cases were identified over the
follow-up period and matched to 549 controls. Insufficient sample for
analysis led to missing values for 4 cases and 3 controls. After their
exclusion, as well as that of any sets with no cases or controls, 271 cases and
538 controls were available for the present analysis.
Laboratory assays
All assays were performed at the University of Hawaii Cancer Center in the
laboratory of Dr Adrian Franke. Frozen serum samples were retrieved from
the MEC biorepository in matched case-control sets, thawed, and analyzed
together within batches. The laboratory personnel were blinded to the
case-control status of the samples. High-pressure liquid chromatography
with photodiode array detection, according to our previous protocol,35-37
was used to obtain carotenoid concentrations. This assay is continuously
validated by quality assurance programs organized by the US National
Institute of Standards and Technology. In addition, replicate samples of
pooled serum were included in each analysis batch for quality control.
Based on 27 duplicate and 9 triplet samples, the average intrabatch
coefficient of variation (CV) was less than 4.1% and the average interbatch
CV was less than 9.1% for all analytes. Serum triglycerides and cholesterol
were measured using an automated chemical analyzer (Cobas, MiraPlus,
Roche Diagnostics).
Statistical analysis
Data analyses were performed using SAS Version 9.2 statistical software.
All tests were 2-sided; P less than .05 was considered statistically
significant. Characteristics of cases and controls were compared using
2 tests for categorical variables, t tests for normally distributed
continuous variables, and the nonparametric Wilcoxon rank-sum test for
non-normally distributed variables. Spearman correlation coefficients
were computed between serum carotenoids and intake estimates derived
from the baseline FFQ.33
Conditional logistic regression with matched sets as strata was used to
calculate odds ratios (ORs) and 95% confidence intervals (CIs) for NHL.
Tertiles of serum carotenoids were examined in all models using cut-points
based on the exposure distribution of the total study population to optimize
the distribution of cases and controls within strata. The lowest exposure
group served as the referent in all models. Linear trends were assessed by
Wald tests of the parameter estimates for the natural log–transformed
continuous variables. Years of education; alcohol consumption; pack-years
of cigarette smoking; BMI, physical activity; history of blood transfusion;
history of asthma; use of antihistamine, aspirin, and other nonsteroidal
anti-inflammatory drugs; and serum triglycerides, and high-density, low-
density, and total cholesterol were examined as potential confounders but
were not included in the final models because they were not found alone, or
in combination, to change the risk estimates by more than 10%.38
Sensitivity analyses were performed by excluding participants diagnosed
with NHL within 1 year after the date of blood draw.
Associations between serum carotenoids and the risk of NHL also were
examined in analyses stratified by sex, ethnicity, and common NHL
subtypes.3 Common subtypes included diffuse large B-cell lymphoma
(DLBCL), follicular lymphoma (FL), chronic lymphocytic leukemia or
small lymphocytic lymphoma (CLL/SLL), T-cell lymphoma (all types), and
all other NHL subtypes. No separate ORs were calculated for the latter
2 categories because of the limited number of T-cell cases (n 15) and the
subtype heterogeneity for the cases classified as “other.” Heterogeneity in
the risk estimates by sex and ethnicity was assessed using a Wald test of the
cross-product terms and across the 3 NHL subtypes using a Wald test of the
parameter estimates obtained from unconditional polytomous logistic
regression adjusting for the matching factors and comparing case subgroups
to all controls.
Results
The mean age at blood draw of both cases and controls was
70 years (Table 1), and the median time from the date of blood
draw to the date of diagnosis was 2.7 years. Whites comprised the
largest ethnic group (28%), followed by Japanese Americans
(26%), Latinos (23%), blacks (17%), and Native Hawaiians (6%).
No differences in the levels of educational attainment, BMI,
pack-years of cigarette smoking, physical activity, alcohol consump-
tion, or positive history of blood transfusion were detected between
cases and controls (P  .05). The serum concentrations of total
carotenoids, lycopene, dihydrolycopene, and -cryptoxanthin were
significantly lower for cases than for controls (P  .05); the
differences in levels by case-control status did not reach statistical
significance for 	-carotene and trans-lutein (P  .08 and .09,
respectively) or for -carotene, 	-cryptoxanthin, trans-zeaxanthin,
and retinol. The majority of NHL cases were of B-cell origin
( 94%) and classified as diffuse DLBCL (29%), CLL/SLL (19%),
FL (18%), or other NHL B-cell subtypes (29%), with a small
number of T-cell lymphomas (6%) diagnosed over the follow-up
period.
Higher serum levels of total carotenoids (ORT3 vs T1  0.66
[0.46-0.96]; Ptrend  .02), lycopene (OR  0.54 [0.38-0.78];
Ptrend  .003), dihydrolycopene (OR  0.51 [0.35-0.73];
Ptrend  .007), and -cryptoxanthin (OR  0.53 [0.36-0.78];
Ptrend  .003) were associated with a lower risk of NHL (Table 2).
A statistically significant inverse trend was detected for retinol
(Ptrend  .04); however, risk estimates did not depart from unity in
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models examining tertiles of exposure. The risk estimates for
	-carotene (OR 0.77 [0.53-1.12]; Ptrend  .06) and trans-lutein
(OR 0.71 [0.48-1.04]; Ptrend .08) included 1. No statistically signifi-
cant associations were detected for -carotene, 	-cryptoxanthin,
and trans-zeaxanthin. The associations were similar in a sensitivity
analyses excluding the cases (n 53) diagnosed with NHL within
1 year after the date of blood draw and their matched controls;
however, the risk estimate for total carotenoids (OR 0.72
[0.48-1.10]; Ptrend  .11) no longer departed from unity.
No heterogeneity in the risk estimates was detected in analyses
stratified by sex (P  .77) or by ethnicity (P  .99; data not
shown). After stratification by common NHL subtype (Table 3), the
inverse association for higher serum levels of total carotenoids,
	-carotene, lycopene, and dihydrolycopene was confined to DLBCL.
At the same time, -cryptoxanthin remained inversely associated
with DLBCL and CLL/SLL and serum retinol with the risk of
DLBCL and FL. However, statistically significant heterogeneity in
risk estimates across histologic subtypes was detected only for
	-carotene (P  .0001).
A comparison of serum levels with energy-adjusted nutrient
intake levels based on the baseline FFQ showed Spearman
correlation coefficients of 0.21 for total carotenoids, 0.29 for
-carotene, 0.27 for 	-carotene, and 0.16 for lycopene and lutein
(P  .0001 for all).
Discussion
In this nested case-control study, prediagnostic total carotenoids
measured in serum were associated with a reduced risk of NHL; in
particular, lycopene and -cryptoxanthin were associated with a
30% to 50% lower risk of disease. Risk estimates for 	-carotene,
lutein, and retinol were also suggestive of a protective effect. When
stratified by common NHL subtype, significant associations were
generally confined to DLBCL, probably reflecting the small
number of cases for the other subtypes examined. Given the lack of
an a priori hypothesis, the subtype heterogeneity for 	-carotene
may represent a chance finding and requires replication.
To the best of our knowledge, no previous study has directly
investigated the association between prediagnostic serum carot-
enoid levels and the risk of NHL. Previous studies, in agreement
with our findings in blood, have reported inverse associations for
individual carotenoids estimated from FFQs,9,10,12-14,18,21 as well as
for carotenoid-rich foods, including green leafy vegetables9-15 and
yellow-orange vegetables.9,10,17,20,21 Associations for the intake of
fruits in relation to the risk of NHL have been less consistent.9,16,19
In addition to the potential for recall bias in retrospective case-
controls studies of diet, the difficulty in obtaining precise estimates
of carotenoids levels when measured by a FFQ raises concerns
Table 1. Characteristics of participants in the NHL nested case-control study
Characteristic Cases (n  271) Controls (n  538) P*
Mean age at blood draw, y (SD)† 70.0 (7.4) 70.0 (7.5)
Hours fasting before blood draw, mean (SD)† 12.0 (4.0) 12.3 (4.1)
Male, n (%)† 157 (57.9) 312 (58.0)
Ethnicity, n (%)†
Black 46 (17.0) 92 (17.1)
Native Hawaiian 17 (6.3) 33 (6.1)
Japanese American 72 (26.6) 142 (26.4)
Latino 62 (22.9) 123 (22.9)
White 74 (27.3) 148 (27.5)
Years of education, mean (SD) 13.7 (3.0) 13.7 (3.2) .88
Mean BMI, kg/m2 (SD) 26.9 (5.3) 26.4 (4.3) .16
Pack-years of cigarette smoking, mean (SD) 10.5 (15.1) 9.8 (15.2) .54
Mean physical activity, h/d (SD) 1.2 (1.2) 1.3 (1.4) .29
Mean alcohol intake, g/d (SD) 9.7 (24.4) 11.2 (28.4) .43
Positive history of blood transfusion, n (%) 23 (8.5) 53 (9.9) .53
NHL subtype, n (%)
DLBCL 78 (28.8)
Follicular lymphoma 49 (18.1)
T-cell lymphomas 15 (5.5)
SLL/CLL 51 (18.8)
Other types 78 (28.8)
Total carotenoids, ng/mL‡ 1184 (862-1659) 1326 (965-1769) .02
-carotene, ng/mL 48 (29-81) 54 (32-83) .20
	-carotene, ng/mL 224 (118-440) 264 (147-430) .08
Lycopene, ng/mL 370 (275-521) 439 (320-583)  .01
Dihydrolycopene, ng/mL 93 (67-127) 107 (79-138)  .01
trans-lutein, ng/mL 96 (73-129) 104 (78-138) .09
-cryptoxanthin, ng/mL 30 (22-41) 33 (26-43)  .01
	-cryptoxanthin, ng/mL 156 (103-270) 168 (106-295) .45
trans-zeaxanthin, ng/mL 20 (16-26) 20 (16-26) .87
Retinol, ng/mL 648 (527-798) 661 (562-780) .19
DLBCL indicates diffuse large B-cell lymphoma; and SLL/CLL, small lymphocytic lymphoma/chronic lymphocytic lymphoma.
*P values obtained by 2 test for categorical variables; t tests were performed for all continuous variables except for the non-normally distributed carotenoids, for which a
nonparametric Wilcoxon rank-sum test was used.
†Matching variable; cases and controls were matched on sex, birth year ( 1 year), location (Hawaii or California), ethnicity, date of blood draw ( 1 year), time of blood
draw ( 2 hours), and hours fasting before blood draw ( 6, 6 to 8, 8 to 10, 10).
‡Medians and 25th-75th percentiles are presented for carotenoids and retinol.
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regarding previous findings. As shown by the modest correlations
of 0.16 to 0.29 in our population, serum carotenoid levels do not
represent the same exposure as FFQ-based dietary intakes. Thus,
prospective analyses of circulating carotenoid levels probably
provide for a more valid assessment. Interactions between the
intake of vegetables and genetic polymorphisms in pathways
involved in oxidative stress, DNA repair, and carcinogen metabo-
lism in relation to NHL risk may influence the results of individual
studies, in particular those with null findings,22-26 and warrant
further examination.39,40
Despite our lack of a priori hypothesis and the limited evidence
of heterogeneity across common NHL subtypes examined in our
analysis, the finding of significant risk estimates primarily confined
to DLBCL agrees with several previous reports.12-14,23,24 However,
inverse associations with dietary intake of carotenoids have been
reported for other NHL subtypes.11,21
Multiple mechanisms of action for carotenoids in relation to
NHL have been proposed. Carotenoids, functioning as antioxi-
dants, may reduce the potential for malignant transformation of
lymphoid cells by limiting DNA damage induced by ROS and
reactive nitrogen species. In addition to genotoxic effects, ROS
have been implicated in tumor promotion and may adversely affect
the rates of cellular proliferation and differentiation.41 Carotenoids
also may influence the risk of NHL through immune-mediated
pathways.31,42 For example, elderly subjects who received supple-
mentation with carotenoid-containing vitamins and trace elements
showed a higher production of the cytokine IL-2 and a lower rate of
infections,43 and a carotenoid-rich vegetable intervention sup-
pressed the secretion of IL-2 and IL-4.44,45
This study had several strengths, including the prospective
design that allowed for the prediagnostic assessment of serum
carotenoid levels, the ethnic diversity of the study sample, and the
population-based sampling frame allowing for generalizability of
results. Although NHL diagnoses could not be confirmed by the
rereview of pathology records, the majority of histologic subtypes
are expected to be correctly classified within the Surveillance,
Epidemiology, and End Results registry; all cases were diagnosed
after the International Classification of Diseases for Oncology,
Table 2. Association of NHL with tertiles of serum carotenoids
Biomarker T1 T2 T3 Ptrend*
Total carotenoids, ng/mL
Tertile cut-points  1040.49 1040.49-1550.33  1550.34
Cases/controls 109/159 76/195 86/184
OR (95% CI) 1.00 0.56 (0.38-0.81) 0.66 (0.46-0.96) .02
-carotene, ng/mL
Tertile cut-points  38.53 38.53-68.75  68.76
Cases/controls 102/169 80/190 89/179
OR (95% CI) 1.00 0.70 (0.49-1.00) 0.81 (0.56-1.17) .34
-carotene, ng/mL
Tertile cut-points  167.52 167.52-353.05  353.06
Cases/controls 101/164 79/188 91/186
OR (95% CI) 1.00 0.67 (0.47-0.97) 0.77 (0.53-1.12) .06
Lycopene, ng/mL
Tertile cut-points  345.70 345.70-510.43  510.44
Cases/controls 109/155 87/184 75/199
OR (95% CI) 1.00 0.68 (0.48-0.97) 0.54 (0.38-0.78) .003
Dihydrolycopene, ng/mL
Tertile cut-points  85.14 85.14-122.47  122.48
Cases/controls 110/155 88/182 73/201
OR (95% CI) 1.00 0.69 (0.48-0.98) 0.51 (0.35-0.73) .007
trans-lutein, ng/mL
Tertile cut-points  84.33 84.33-122.36  122.37
Cases/controls 95/173 98/174 78/191
OR (95% CI) 1.00 1.03 (0.73-1.46) 0.71 (0.48-1.04) .08
-cryptoxanthin, ng/mL
Tertile cut-points  27.16 27.16-37.72  37.73
Cases/controls 112/158 79/187 80/193
OR (95% CI) 1.00 0.57 (0.40-0.82) 0.53 (0.36-0.78) .003
-cryptoxanthin, ng/mL
Tertile cut-points  126.45 126.45-232.90  232.91
Cases/controls 90/181 100/169 81/188
OR (95% CI) 1.00 1.18 (0.83-1.68) 0.84 (0.57-1.24) .55
trans-zeaxanthin, ng/mL
Tertile cut-points  16.92 16.92-24.05  24.06
Cases/controls 88/180 96/177 87/181
OR (95% CI) 1.00 1.12 (0.78-1.60) 0.98 (0.68-1.43) .66
Retinol, ng/mL
Tertile cut-points  587.75 587.75-740.43  740.44
Cases/controls 98/176 84/186 89/176
OR (95% CI) 1.00 0.81 (0.56-1.16) 0.90 (0.61-1.33) .04
ORs and 95% CI estimated from conditional logistic regression with matched sets as strata. Cases and controls were matched on sex, age ( 1 year), location (Hawaii or
California), ethnicity, date of blood draw ( 1 year), time of blood draw ( 2 hours), and hours fasting before blood draw ( 6, 6 to 8, 8 to 10, 10).
*P value for the Wald 2 test of Ho: 	  0 when modeling the natural log–transformed continuous variable.
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Third Edition classification had been adopted.3 There were also
limitations. Only a single biologic sample was available for this
analysis. Because seasonal variations have been observed for these
nutrients,36 misclassification may have attenuated the risk esti-
mates. However, in contrast to other nutrients, intraindividual
circulating carotenoid levels seem to be relatively stable over
time.46,47 For example, an intraclass correlation coefficient of
0.82 to 0.84 over 2 to 4 weeks was reported previously.46 The
fat-soluble nature and the relatively long half-life of carotenoids,
estimated as 26 to 76 days in 1 report,48 contribute to this stability.
Despite the potential for higher sun exposure in Hawaii and
California, we consider it unlikely that vitamin D intake influenced
the findings through competitive binding with retinol because a
large pooling project of cohort studies did not detect an association
between circulating vitamin D and NHL risk and vitamin D levels
within the MEC were comparable with other sites.49
Table 3. Association of NHL subtypes with tertiles of serum carotenoids
Controls
DLBCL FL CLL/SLL
Pheterogeneity*Cases OR (95% CI) Cases OR (95% CI) Cases OR (95% CI)
Total carotenoids, ng/mL
 1040.49 159 37 1.00 15 1.00 20 1.00
1040.49-1550.33 195 20 0.42 (0.23-0.76) 15 0.86 (0.40-1.86) 15 0.59 (0.29-1.21)
 1550.34 184 21 0.46 (0.25-0.84) 19 1.07 (0.51-2.27) 16 0.73 (0.36-1.49)
Ptrend†  0.01 0.27 0.34 .29
-carotene, ng/mL
 38.53 169 35 1.00 16 1.00 20 1.00
38.53-68.75 190 19 0.47 (0.25-0.85) 14 0.69 (0.32-1.49) 17 0.85 (0.42-1.71)
 68.76 179 24 0.62 (0.34-1.11) 19 0.96 (0.46-2.03) 14 0.77 (0.36-1.62)
Ptrend 0.24 0.48 0.64 .89
-carotene, ng/mL
 167.52 164 38 1.00 15 1.00 18 1.00
167.52-353.05 188 21 0.44 (0.24-0.79) 16 0.94 (0.44-2.02) 15 0.78 (0.37-1.62)
 353.06 186 19 0.38 (0.20-0.71) 18 1.04 (0.48-2.26) 18 0.95 (0.46-1.96)
Ptrend  0.01 0.89 0.84  .01
Lycopene, ng/mL 3w1112
 345.70 155 34 1.00 18 1.00 17 1.00
345.70-510.43 184 22 0.54 (0.30-0.96) 18 0.85 (0.42-1.72) 22 1.11 (0.56-2.20)
 510.44 199 22 0.51 (0.28-0.91) 13 0.53 (0.25-1.14) 12 0.52 (0.24-1.15)
Ptrend  0.01 0.12 0.19 .44
Dihydrolycopene, ng/mL
 85.14 155 32 1.00 18 1.00 19 1.00
85.14-122.47 182 26 0.68 (0.39-1.20) 17 0.84 (0.41-1.73) 21 0.92 (0.47-1.80)
 122.48 /201 20 0.49 (0.27-0.89) 14 0.54 (0.26-1.16) 11 0.45 (0.20-0.99)
Ptrend 0.01 0.11 0.23 .59
trans-lutein, ng/mL
 84.33 173 28 1.00 21 1.00 18 1.00
84.33-122.36 174 3 1.06 (0.60-1.86) 13 0.59 (0.28-1.26) 22 1.21 (0.62-2.37)
 122.37 191 20 0.62 (0.33-1.17) 15 0.64 (0.31-1.35) 11 0.59 (0.26-1.30)
Ptrend 0.16 0.28 0.10 .93
-cryptoxanthin, ng/mL
 27.16 158 36 1.00 19 1.00 25 1.00
27.16-37.72 187 25 0.57 (0.32-1.00) 12 0.48 (0.22-1.03) 9 0.27 (0.12-0.60)
 37.73 193 17 0.35 (0.19-0.68) 18 0.76 (0.37-1.57) 17 0.47 (0.23-0.95)
Ptrend 0.02 0.10 0.07 .99
-cryptoxanthin, ng/mL
 126.45 181 33 1.00 15 1.00 16 1.00
126.45-232.90 171 21 0.64 (0.35-1.16) 22 1.50 (0.74-3.05) 21 1.45 (0.72-2.93)
 232.91 186 24 0.66 (0.36-1.21) 12 0.70 (0.31-1.61) 14 1.04 (0.47-2.28)
Ptrend 0.49 0.74 0.71 .98
trans-zeaxanthin, ng/mL
 16.92 180 25 1.00 16 1.00 19 1.00
16.92-24.05 177 30 1.21 (0.68-2.15) 14 0.85 (0.39-1.83) 21 1.19 (0.61-2.32)
 24.06 181 23 0.90 (0.48-1.66) 19 1.25 (0.60-2.60) 11 0.60 (0.27-1.32)
Ptrend 0.87 0.89 0.24 .67
Retinol, ng/mL
 587.75 176 27 1.00 26 1.00 18 1.00
587.75-740.43 186 30 1.03 (0.59-1.81) 13 0.49 (0.24-0.99) 14 0.69 (0.33-1.44)
 740.44 176 21 0.75 (0.40-1.40) 10 0.47 (0.21-1.04) 19 0.83 (0.41-1.67)
Ptrend 0.02 0.03 0.73 .48
ORs and 95% CI estimated from conditional logistic regression with matched sets as strata. Cases and controls were matched on sex, age ( 1 year), study site (Hawaii or
California), ethnicity, date of blood draw ( 1 year), time of blood draw ( 2 hours), and hours fasting prior to blood draw ( 6, 6 to 8, 8 to 10, 10).
*P value for the test of heterogeneity in the parameter estimates for the log-transformed continuous variables across the NHL subtypes.
†P value for the Wald 2 of Ho: 	  0 when modeling the natural log–transformed continuous variable.
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Furthermore, the median follow-up time from the date of blood
draw to the date of diagnosis for this analysis was less than
2.7 years. Despite this relatively short follow-up period, no differ-
ences in the risk estimates were detected in sensitivity analyses
excluding cases diagnosed within the first year of providing a
biologic specimen. Longer follow-up of the MEC and other cohorts
is needed to confirm these findings with greater statistical power.
Although information on HIV status, family history of lymphoma,
presence of autoimmune disease, immunosuppression, or agricul-
tural exposure was not available and could not be examined as
potential confounders, these conditions are expected to be rare in
this relatively healthy cohort population. In addition, the small
number of cases limited our ability to detect statistically significant
associations in subgroup analyses. Finally, the characteristics of
our study population with a mean age of 70 years and relatively
high carotenoid levels limit the generalizability of our findings to
younger individuals and to those with lower carotenoid exposure.
Compared with a value of 1284 ng/mL in the MEC, the 2003 to
2006 US data show median levels of  770 ng/mL for total
carotenoids in adults 60 years of age or older.50
In conclusion, our findings provide support for the hypothesis
that higher levels of circulating carotenoids, presumably from the
consumption of carotenoid-rich foods, are associated with a lower
risk of NHL. Additional prospective studies and longer follow-up
of the MEC and other cohorts over time are needed to confirm these
findings in larger populations and to establish long-term relations
between serum carotenoids and NHL risk. To further elucidate the
role of prediagnostic circulating carotenoids for specific common
NHL subtypes, pooled analyses of prospective data are needed. In
addition, future studies focused on investigating whether circulat-
ing carotenoids may influence the risk of NHL through oxidative
stress pathways or through immune function may provide further
insights. Non-invasive approaches to measure carotenoid levels,
eg, dermal resonance Raman spectroscopy, may facilitate exposure
assessment for such epidemiologic studies in the future.51
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